GR 270773
Alternative Names: GR 270773 Emulsion; GR 270773XLatest Information Update: 10 Jul 2023
At a glance
- Originator Sepsicure
- Developer GSK
- Class Antibacterials
- Mechanism of Action Endotoxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Sepsis; Septic shock
Most Recent Events
- 29 Sep 2017 Discontinued - Phase-I for Sepsis (In volunteers) in Slovakia (IV)
- 24 Jan 2006 Data presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2005) have been added to the drug interactions section
- 31 Dec 2003 Phase-II clinical trials in Sepsis in United Kingdom (unspecified route)